Side-by-side comparison of AI visibility scores, market position, and capabilities
Carbon capture device for semi trucks and freight trains reducing diesel exhaust; $117M raised from Lowercarbon and USV with Union Pacific and Norfolk Southern partnerships.
Remora is a Detroit-based climate technology company building carbon capture devices that attach to semi trucks and freight trains — capturing CO2 from diesel exhaust while simultaneously reducing soot, particulate matter, and NOx by up to 90%, then purifying and selling the captured CO2 to industrial buyers. Founded and a Y Combinator W21 graduate, Remora raised $117 million from Lowercarbon Capital, Valor Equity Partners, Union Square Ventures, and Y Combinator (Series A in February 2024), with partnerships established with Union Pacific, Norfolk Southern, Ryder, and Werner Enterprises.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.